Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
-463K
-
Total reported value, excl. options
-
$864M
-
Value change
-
-$4.74M
-
Put/Call ratio
-
1.36
-
Number of buys
-
58
-
Number of sells
-
-68
-
Price
-
$13.11
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q2 2018
156 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q2 2018.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
of 129M outstanding shares and own 50.99% of the company stock.
Largest 10 shareholders include GENERAL ELECTRIC CO (15M shares), JANUS HENDERSON GROUP PLC (6.16M shares), First Light Asset Management, LLC (5.16M shares), BlackRock Inc. (4.15M shares), VANGUARD GROUP INC (3.1M shares), Russell Investments Group, Ltd. (2.46M shares), Artisan Partners Limited Partnership (2.18M shares), Granite Investment Partners, LLC (1.62M shares), EMERALD ADVISERS INC/PA (1.37M shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.21M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.